logo
Las Vegas mayor bullish on chances for Cashman sale

Las Vegas mayor bullish on chances for Cashman sale

Yahoo22-02-2025

LAS VEGAS (KLAS) – Las Vegas Mayor Shelley Berkley said she expects a second attempt to auction Cashman Field and the surrounding buildings to net a buyer who will develop the 50-acre parcel into 'a building there that is going to be very beneficial to the city.'
Berkley, at her first news conference since taking office late last year, said she is fielding offers ranging from sports venues to industrial use. But nobody bid at the city's first auction of the Cashman land last November.
At Berkley's own admission, the terms of that sale requiring a bidder to purchase the land before the city reviewed its application, made the process too restrictive and a 'little bit onerous.'
Berkley ran her mayoral campaign, among other things, on her plan to rid the city of the $636 million albatross in the wake of the notorious Badlands golf course litigation. Selling the Cashman land, she has said, is part of that plan.
But describing the flaws in the prior auction process, Berkley said, 'You buy it, you pay us, and then we'll decide later if we're going to like your project.'
The mayor said the city council agreed to change the regulations so a successful bidder would 'have a pretty good idea if that would be accepted by the city council.'
But Las Vegas resident Tera Anderson, vice president of a national real estate development firm who said the first auction's terms were 'far too limiting,' told the 8 News Now Investigators the city needs to loosen those restrictions and make sure it has a plan worthy of the desirable real estate.
'I think the path that they're on is fraught with tremendous risk to the city and not maximizing the opportunity that is this site,' Anderson said Friday. She said the Cashman land is irreplaceable if, for no other reason, 50 Acres in downtown Las Vegas don't come up for sale very often. Done correctly a development could lead to tremendous growth downtown.
If not, she said, it could end up sitting vacant for another decade.The mayor, in office for some 10 weeks, said the property had recently increased in value by a couple of million dollars.
The city has attempted to redevelop and revitalize the area since it acquired the property in 2017.
The 10,000-seat stadium has been home to various sporting events since the 1940s — from Major League Baseball to football games and political events.
It also housed served as a mass vaccination site during the COVID pandemic.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Novavax Stock (NVAX) Gets a Boost from ‘Robust Immune Responses'
Novavax Stock (NVAX) Gets a Boost from ‘Robust Immune Responses'

Business Insider

timean hour ago

  • Business Insider

Novavax Stock (NVAX) Gets a Boost from ‘Robust Immune Responses'

Novavax (NVAX) stock jumped on Wednesday after the vaccine maker released results from a Phase 3 clinical trial of its COVID-19-Influenza Combination (CIC) and stand-alone flu vaccine. The initial cohort results from this study included 'robust immune responses' for the CIC and flu vaccine that were comparable to licensed rivals Nuvaxovid and Fluzone HD. Confident Investing Starts Here: Additionally, Novavax noted that the two vaccines were well tolerated. Almost all of the adverse events, greater than 98%, that were experienced by patients were mild or moderate in severity. The trial includes roughly 2,000 patients aged 65 or older. Novavax stated that it will continue to seek partners to further the development of its CIC and stand-alone flu vaccines. The results from this study provide it with the data it needs for discussions with potential partners. NVAX Stock Movement Today While NVAX stock had soared more than 2% in pre-market trading, the company couldn't maintain those gains. As a result, the stock is only up 0.56% as of Wednesday morning. Investors will also note that shares are down 8.83% year-to-date and 54.6% over the past 12 months. The Phase 3 clinical trial data also failed to attract investor interest today. Trading volume was muted at 1.38 million shares, compared to a three-month daily average of roughly 11.29 million units. Is Novavax Stock a Buy, Sell, or Hold? Turning to Wall Street, the analysts' consensus rating for Novavax is Hold, based on one Buy, two Hold, and a single Sell rating over the past three months. With that comes an average NVAX stock price target of $11.25, representing a potential 55.39% upside for the shares. Spark, TipRanks' AI analyst, highlighted 'strong revenue growth and profitability improvements' but warned of 'negative equity and cash flow challenges.'

Editorial: Ax to the vax — RFK Jr. continues on his anti-vaccine warpath
Editorial: Ax to the vax — RFK Jr. continues on his anti-vaccine warpath

Yahoo

time2 hours ago

  • Yahoo

Editorial: Ax to the vax — RFK Jr. continues on his anti-vaccine warpath

It's time for President Donald Trump, despite his own casual relationship with the truth, to stop putting American lives at risk and get rid of his dangerous quack in chief, Health and Human Services Secretary Robert F. Kennedy Jr. In his latest broadside against science, Kennedy is removing all 17 members of the Advisory Committee for Immunization Practices, the CDC's main advisory body, to ostensibly restore 'public trust above any specific pro- or anti-vaccine agenda.' God protect us, as RFK won't. This is how a society becomes undone. Science and reason get stepped on by half-truths and conspiracy theories. Next comes preventable death and disease. The problem is that there is no anti-vaccine side in the legitimate practice of science and medicine. The department's accompanying press release denigrated 'public health ideology' as if the practice of public health wasn't the CDC's only function. Researchers and doctors should be biased in favor of evidence-based therapeutics that save lives. Railing against bias towards vaccines is like a politician condemning researchers biased in favor of seatbelts in cars or keeping lead out of household paint. It's idiotic. We understand that the Make America Healthy Again movement Kennedy leads is all about questioning medical and nutritional practice. On a really abstract level, we are in agreement that no scientific truisms should be entirely above questioning — such a perspective would be anti-science. But there is a specific and long-standing methodology for actually answering those questions, and it is not debate club or who can most incite crowds of followers. It is the scientific method, under which hypotheses can be rigorously tested in ways that are replicable and based on clear and clearly laid out evidence. In that arena — really the only arena that actually matters when it comes to public health — the safety and efficacy of vaccines has been conclusively established. There is no additional discussion necessary or appropriate, particularly when it comes to immunizations that have now been standard-issue for decades and have by all measures radically decreased illness and mortality where they've been successfully deployed. The measles vaccine will always be better for individuals and public health than getting the measles. The same is true for polio, tetanus, COVID and all else. Preying on public skepticism of the pharmaceutical and health industries to hawk alternative approaches that are often unregulated and don't work is damaging it enough. Yet a true believer like RFK is more dangerous, especially now that he stands at the pinnacle of our nation's public health bureaucracy, a position that allows him to substantively impose his own anti-science view on an unsuspecting public and take the choice away from the American people. If RFK's new picks for ACIP — which the secretary falsely promised Sen. Bill Cassidy he wouldn't touch during his confirmation process — step back from recommending various crucial vaccines, this could substantially prevent even those who want to make the informed decision to receive inoculations or have their children vaccinated from being able to do so. As much as Kennedy and his followers emphasize the need for people to be able to make individual choices about their health, they seem hell-bent on taking that choice away entirely, especially given that insurance is not required to cover vaccines that are not CDC-recommended. We wonder what RFK will have to say for himself as once-eradicated diseases begin cutting through the U.S. population again. Is there anything that will get him to veer off this disastrous course? If the answer is no, and we suspect it is, then he must be removed before he can further damage public health. _____

Covid-19 India Cases 2025 Live Updates: Active cases cross 7,000-mark — not Delhi, West Bengal or Maharashtra but this state has most cases
Covid-19 India Cases 2025 Live Updates: Active cases cross 7,000-mark — not Delhi, West Bengal or Maharashtra but this state has most cases

Business Upturn

time5 hours ago

  • Business Upturn

Covid-19 India Cases 2025 Live Updates: Active cases cross 7,000-mark — not Delhi, West Bengal or Maharashtra but this state has most cases

By Aditya Bhagchandani Published on June 12, 2025, 10:07 IST India has seen a fresh rise in Covid-19 infections with active cases crossing the 7,000 mark as of June 12, 2025. The country now has a total of 7,154 active cases, as per data released by the Ministry of Health and Family Welfare. Importantly, six new Covid-related deaths have been reported in the last 24 hours — two from Maharashtra, one from Madhya Pradesh, and three others under review. Kerala leads the chart as worst-hit state Despite no recent headlines from major metros like Delhi, Kolkata, or Mumbai, it is Kerala that continues to top the active caseload in India with 2,165 active cases, accounting for over 30% of the national burden. Gujarat (1,281), West Bengal (747), Delhi (731), and Maharashtra (615) are also witnessing relatively high numbers. New Omicron variants fuelling mild surges Health experts attribute the recent rise to highly transmissible but less severe Omicron sub-variants such as JN.1, NB.1.8.1, LF.7, and XFC. These strains have been classified by the WHO as 'Variants Under Monitoring,' meaning they are not currently considered dangerous but are being tracked closely. Covid becoming part of seasonal cycles While SARS-CoV-2 has not disappeared, its pattern of recurrence has now become more predictable, similar to influenza. The ongoing infections mostly result in milder symptoms, but vulnerable populations are advised to remain cautious and follow preventive protocols. Aditya Bhagchandani serves as the Senior Editor and Writer at Business Upturn, where he leads coverage across the Business, Finance, Corporate, and Stock Market segments. With a keen eye for detail and a commitment to journalistic integrity, he not only contributes insightful articles but also oversees editorial direction for the reporting team.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store